CDC vs. BTAL

Last updated Apr 1, 2026

Compare and contrast key facts about VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) and AGFiQ US Market Neutral Anti-Beta Fund (BTAL).

CDC and BTAL are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. CDC is a passively managed fund by Crestview that tracks the performance of the Nasdaq Victory U.S. Large Cap High Dividend 100 Long/Cash Volatility Weighted Index. It was launched on Jul 2, 2014. BTAL is a passively managed fund by AGF that tracks the performance of the Dow Jones U.S. Thematic Market Neutral Anti-Beta Total Return Index. It was launched on Sep 13, 2011. Both CDC and BTAL are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

CDC vs. BTAL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) and AGFiQ US Market Neutral Anti-Beta Fund (BTAL). The values are adjusted to include any dividend payments, if applicable.

CDC vs. BTAL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF	9.03%	8.96%	14.48%	-4.99%	-7.86%	33.05%	12.88%	19.64%	-5.97%	15.77%
BTAL AGFiQ US Market Neutral Anti-Beta Fund	-2.99%	-20.17%	12.83%	-15.11%	20.48%	-6.81%	-13.86%	1.07%	15.13%	-2.13%

Returns By Period

In the year-to-date period, CDC achieves a 9.03% return, which is significantly higher than BTAL's -2.99% return. Over the past 10 years, CDC has outperformed BTAL with an annualized return of 10.00%, while BTAL has yielded a comparatively lower -3.16% annualized return.

CDC

• 1D: 0.77%
• 1M: -2.88%
• YTD: 9.03%
• 6M: 8.89%
• 1Y: 12.52%
• 3Y*: 9.63%
• 5Y*: 6.27%
• 10Y*: 10.00%

BTAL

• 1D: -2.72%
• 1M: -0.85%
• YTD: -2.99%
• 6M: -10.10%
• 1Y: -31.33%
• 3Y*: -8.29%
• 5Y*: -1.50%
• 10Y*: -3.16%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CDC vs. BTAL - Expense Ratio Comparison

CDC has a 0.37% expense ratio, which is lower than BTAL's 2.11% expense ratio.

BTAL

AGFiQ US Market Neutral Anti-Beta Fund

CDC

VictoryShares US EQ Income Enhanced Volatility Wtd ETF

Return for Risk

CDC vs. BTAL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CDC

CDC Risk / Return Rank: 51
CDC Sharpe Ratio Rank: 53
CDC Sortino Ratio Rank: 50
CDC Omega Ratio Rank: 50
CDC Calmar Ratio Rank: 49
CDC Martin Ratio Rank: 52

BTAL

BTAL Risk / Return Rank: 1
BTAL Sharpe Ratio Rank: 0
BTAL Sortino Ratio Rank: 0
BTAL Omega Ratio Rank: 0
BTAL Calmar Ratio Rank: 1
BTAL Martin Ratio Rank: 3

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CDC vs. BTAL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) and AGFiQ US Market Neutral Anti-Beta Fund (BTAL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CDC	BTAL	Difference
Sharpe ratio Return per unit of total volatility	0.93	-1.40	+2.32
Sortino ratio Return per unit of downside risk	1.33	-2.13	+3.45
Omega ratio Gain probability vs. loss probability	1.19	0.77	+0.41
Calmar ratio Return relative to maximum drawdown	1.23	-0.88	+2.10
Martin ratio Return relative to average drawdown	4.90	-1.20	+6.09
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CDC vs. BTAL - Sharpe Ratio Comparison

The current CDC Sharpe Ratio is 0.93, which is higher than the BTAL Sharpe Ratio of -1.40. The chart below compares the historical Sharpe Ratios of CDC and BTAL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CDC	BTAL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.93	-1.40	+2.32
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.50	-0.08	+0.58
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.76	-0.19	+0.95
Sharpe Ratio (All Time) Calculated using the full available price history	0.74	-0.17	+0.91

Correlation

The correlation between CDC and BTAL is -0.37. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.

Dividends

CDC vs. BTAL - Dividend Comparison

CDC's dividend yield for the trailing twelve months is around 3.19%, more than BTAL's 2.56% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF	3.19%	3.36%	3.32%	4.24%	3.48%	2.65%	2.48%	3.04%	3.37%	2.81%	2.99%	3.17%
BTAL AGFiQ US Market Neutral Anti-Beta Fund	2.56%	2.49%	3.49%	6.14%	1.01%	0.00%	0.00%	0.88%	0.39%	0.00%	0.00%	0.00%

Drawdowns

CDC vs. BTAL - Drawdown Comparison

The maximum CDC drawdown since its inception was -21.37%, smaller than the maximum BTAL drawdown of -41.01%. Use the drawdown chart below to compare losses from any high point for CDC and BTAL.

Drawdown Indicators

	CDC	BTAL	Difference
Max Drawdown Largest peak-to-trough decline	-21.37%	-41.01%	+19.64%
Max Drawdown (1Y) Largest decline over 1 year	-11.27%	-34.94%	+23.67%
Max Drawdown (5Y) Largest decline over 5 years	-21.37%	-34.94%	+13.57%
Max Drawdown (10Y) Largest decline over 10 years	-21.37%	-41.01%	+19.64%
Current Drawdown Current decline from peak	-3.07%	-39.53%	+36.46%
Average Drawdown Average peak-to-trough decline	-5.14%	-21.67%	+16.53%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.84%	25.64%	-22.80%

Volatility

CDC vs. BTAL - Volatility Comparison

The current volatility for VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) is 2.97%, while AGFiQ US Market Neutral Anti-Beta Fund (BTAL) has a volatility of 6.87%. This indicates that CDC experiences smaller price fluctuations and is considered to be less risky than BTAL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CDC	BTAL	Difference
Volatility (1M) Calculated over the trailing 1-month period	2.97%	6.87%	-3.90%
Volatility (6M) Calculated over the trailing 6-month period	7.03%	15.84%	-8.81%
Volatility (1Y) Calculated over the trailing 1-year period	13.63%	22.51%	-8.88%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	12.56%	18.36%	-5.80%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	13.22%	17.04%	-3.82%